Oleg Gluz

机构：Bethesda Hospital, Klinik Niederrhein, Evangelisches Krankenhaus Bethesda Mönchengladbach, Women‘s Healthcare Group, University Hospital Cologne · ORCID：0000-0001-6019-7544

发表论文 443 篇 · 总被引 7174 次 · h-index 41

代表论文

• AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025 (2025 · European Journal of Surgical Oncology · 被引 17)
• Prediction of survival after de-escalated neoadjuvant therapy in HER2-positive early breast cancer: a pooled analysis of three WSG trials (2025 · Annals of Oncology · 被引 6)
• A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and nonresponders (2025 · Journal of Clinical Investigation · 被引 5)
• A chemotherapy-free, pathological response-adapted strategy using trastuzumab–pertuzumab and T-DM1 in HER2-positive early breast cancer: the PHERGain-2 study (2026 · Annals of Oncology · 被引 2)
• Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292) (2025 · ESMO Open · 被引 2)
• The role of the 21-gene assay in the neoadjuvant setting for hormone receptor-positive HER2-negative breast cancer: Impact on systemic and surgical treatment decisions (2026 · Cancer Treatment Reviews · 被引 1)